Mizuho lowered the firm’s price target on Iqvia (IQV) to $215 from $266 and keeps an Outperform rating on the shares. The firm updated the company’s model post the Q4 report.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia price target lowered to $245 from $290 at Truist
- Iqvia price target lowered to $174 from $245 at TD Cowen
- IQVIA: Solid 2026 Outlook but AI Disruption Risks Justify Hold Rating and Lowered Valuation
- Iqvia price target lowered to $240 from $265 at Morgan Stanley
- Iqvia announces collaboration with Duke Clinical Research Institute